Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Colchicine in Myocardial Infarction
NCT04218786Phase 2Withdrawn
- Sponsor
- Shifa Tameer-e-Millat University
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in myocardial infarction (MI), sponsored by Shifa Tameer-e-Millat University. Planned start Dec 2025; status: withdrawn.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT04218786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04218786.